Based on a successful pilot, a screening algorithm with Gal-1-P as the first-tier screening test, and GALT enzyme activity as the second-tier to identify newborns suspected to be at risk for classical galactosemia has been implemented [1349]. This evidence concerns the gene GALT and classic galactosemia.